|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.24 USD | +0.18% |
|
-0.31% | +11.26% |
| 30/06 | Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell Small Cap Comp Growth Benchmark | CI |
| 30/06 | Innoviva, Inc.(NasdaqGS:INVA) dropped from Russell 2500 Growth Benchmark | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 24.56 | 12.3 | 7.12 | 8.88 | 7.18 | |||||
Return on Total Capital | 24.71 | 12.63 | 7.43 | 9.39 | 7.76 | |||||
Return On Equity % | 65.06 | 40.35 | 28.97 | 3.42 | 29.09 | |||||
Return on Common Equity | 55.7 | 43.63 | 28.97 | 3.42 | 29.09 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 99.85 | 83.33 | 84.09 | 89.84 | 74.94 | |||||
SG&A Margin | 3.29 | 17.58 | 31.64 | 32.25 | 27.56 | |||||
EBITDA Margin % | 96.57 | 65.79 | 56.93 | 57.63 | 47.41 | |||||
EBITA Margin % | 96.56 | 65.76 | 52.45 | 57.59 | 47.37 | |||||
EBIT Margin % | 96.56 | 64.07 | 45.43 | 50.37 | 40.99 | |||||
Income From Continuing Operations Margin % | 94.12 | 66.48 | 57.89 | 6.52 | 65.92 | |||||
Net Income Margin % | 67.84 | 64.56 | 57.89 | 6.52 | 65.92 | |||||
Net Avail. For Common Margin % | 67.84 | 64.56 | 57.89 | 6.52 | 65.92 | |||||
Normalized Net Income Margin | 30.75 | 35.72 | 26.72 | 30.43 | 25.85 | |||||
Levered Free Cash Flow Margin | 59.35 | 42.39 | 39.7 | 42.13 | 29.68 | |||||
Unlevered Free Cash Flow Margin | 60.06 | 44.75 | 42.89 | 45.41 | 31.76 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.41 | 0.31 | 0.25 | 0.28 | 0.28 | |||||
Fixed Assets Turnover | 19.59T | 186.99 | 96.21 | 119.85 | 53.24 | |||||
Receivables Turnover (Average Receivables) | - | 0.23 | 0.97 | 1.37 | 1.95 | |||||
Inventory Turnover (Average Inventory) | - | - | 1.02 | 0.98 | 2.83 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 54.02 | 3.29 | 9.03 | 2.35 | 14.64 | |||||
Quick Ratio | 53.77 | 2.63 | 7.28 | 2.11 | 13.28 | |||||
Operating Cash Flow to Current Liabilities | 62.65 | 1.49 | 3.7 | 0.8 | 3.96 | |||||
Days Sales Outstanding (Average Receivables) | - | 1.62T | 377.52 | 266.64 | 187.55 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | 357.01 | 374.03 | 129.04 | |||||
Average Days Payable Outstanding | 29.47 | - | 51.47 | 55.04 | 11.93 | |||||
Cash Conversion Cycle (Average Days) | - | - | 683.07 | 585.62 | 304.66 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 75.06 | 108.64 | 76.89 | 75.33 | 28.24 | |||||
Total Debt / Total Capital | 42.88 | 52.07 | 43.47 | 42.96 | 22.02 | |||||
LT Debt/Equity | 75.04 | 90.94 | 76.71 | 46.38 | 27.51 | |||||
Long-Term Debt / Total Capital | 42.86 | 43.59 | 43.37 | 26.46 | 21.46 | |||||
Total Liabilities / Total Assets | 43.23 | 54.06 | 45.72 | 46.88 | 28.27 | |||||
EBIT / Interest Expense | 19.84 | 13.45 | 7.36 | 8.14 | 10.1 | |||||
EBITDA / Interest Expense | 19.84 | 13.81 | 9.31 | 9.36 | 11.77 | |||||
(EBITDA - Capex) / Interest Expense | 19.84 | 13.8 | 9.29 | 9.35 | 11.7 | |||||
Total Debt / EBITDA | 1.04 | 2.82 | 2.91 | 2.5 | 1.69 | |||||
Net Debt / EBITDA | 0.51 | 1.48 | 1.82 | 0.52 | -1.2 | |||||
Total Debt / (EBITDA - Capex) | 1.04 | 2.82 | 2.92 | 2.51 | 1.7 | |||||
Net Debt / (EBITDA - Capex) | 0.51 | 1.48 | 1.83 | 0.52 | -1.2 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 16.35 | -15.45 | -6.3 | 15.54 | 14.67 | |||||
Gross Profit, 1 Yr. Growth % | 16.8 | -29.44 | -8.76 | 23.45 | -4.58 | |||||
EBITDA, 1 Yr. Growth % | 17.21 | -42.4 | -22.48 | 26.87 | -5.67 | |||||
EBITA, 1 Yr. Growth % | 17.22 | -42.42 | -28.55 | 26.87 | -5.68 | |||||
EBIT, 1 Yr. Growth % | 17.22 | -43.9 | -36.56 | 28.1 | -6.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 25.53 | -40.28 | -18.41 | -86.98 | 1.06T | |||||
Net Income, 1 Yr. Growth % | 18.47 | -19.53 | -15.99 | -86.98 | 1.06T | |||||
Normalized Net Income, 1 Yr. Growth % | -0.94 | -1.77 | -33.42 | 31.55 | -2.58 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 42.2 | -17.46 | -7.02 | -83.56 | 811.83 | |||||
Accounts Receivable, 1 Yr. Growth % | 17.86 | -42.13 | 31.22 | 2.72 | 8.05 | |||||
Inventory, 1 Yr. Growth % | - | - | -27.12 | -17.21 | 16.15 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -57.14 | 3.05T | -12.11 | -1.72 | 320.76 | |||||
Total Assets, 1 Yr. Growth % | -7.32 | 32.93 | 0.98 | 4.63 | 25.68 | |||||
Tangible Book Value, 1 Yr. Growth % | -23.18 | -31 | 49.12 | 8.93 | 109.28 | |||||
Common Equity, 1 Yr. Growth % | -23.18 | 36.42 | 19.29 | 2.4 | 69.69 | |||||
Cash From Operations, 1 Yr. Growth % | 16.19 | -44.55 | -30.07 | 33.76 | 4.37 | |||||
Capital Expenditures, 1 Yr. Growth % | - | - | 513.43 | -34.31 | 318.89 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 16.41 | -39.6 | -16.01 | 22.63 | -19.23 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 16.03 | -37 | -13.84 | 22.34 | -19.82 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 22.53 | -0.81 | -10.99 | 4.05 | 15.1 | |||||
Gross Profit, 2 Yr. CAGR % | 22.44 | -9.21 | -18.32 | 6.13 | 8.15 | |||||
EBITDA, 2 Yr. CAGR % | 23.92 | -17.83 | -31.36 | -3.66 | 9.4 | |||||
EBITA, 2 Yr. CAGR % | 23.93 | -17.85 | -34.11 | -3.66 | 9.39 | |||||
EBIT, 2 Yr. CAGR % | 23.93 | -18.91 | -38.68 | -8.75 | 9.33 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 38.97 | -13.42 | -30.2 | -67.41 | 22.83 | |||||
Net Income, 2 Yr. CAGR % | 30.01 | -2.36 | -17.78 | -66.93 | 22.83 | |||||
Normalized Net Income, 2 Yr. CAGR % | 3.79 | -1.36 | -16.3 | -5.15 | 13.2 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 41.75 | 8.34 | -12.39 | -60.9 | 22.44 | |||||
Accounts Receivable, 2 Yr. CAGR % | 18.06 | -17.41 | -12.86 | 16.1 | 5.35 | |||||
Inventory, 2 Yr. CAGR % | - | - | - | -22.32 | -1.94 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -39.7 | 1.01T | 426.28 | -7.06 | 103.35 | |||||
Total Assets, 2 Yr. CAGR % | 13.05 | 11 | 15.86 | 2.79 | 14.67 | |||||
Tangible Book Value, 2 Yr. CAGR % | 15.02 | -27.2 | 1.43 | 27.45 | 50.99 | |||||
Common Equity, 2 Yr. CAGR % | 15.02 | 2.37 | 27.57 | 10.53 | 31.82 | |||||
Cash From Operations, 2 Yr. CAGR % | 18.87 | -19.73 | -37.73 | -3.29 | 18.15 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | 127.02 | - | 100.74 | 65.89 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 17.16 | -16.15 | -26.88 | 2.65 | -0.48 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 16.53 | -14.5 | -24.45 | 3.79 | -0.95 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 14.51 | 8.28 | -2.68 | -2.9 | 7.47 | |||||
Gross Profit, 3 Yr. CAGR % | 14.45 | 1.89 | -7.98 | -6.26 | 2.51 | |||||
EBITDA, 3 Yr. CAGR % | 16.02 | -4 | -18.19 | -18.01 | -4.33 | |||||
EBITA, 3 Yr. CAGR % | 16.03 | -4.01 | -20.4 | -18.03 | -4.34 | |||||
EBIT, 3 Yr. CAGR % | 16.03 | -4.84 | -24.12 | -21.61 | -8.07 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -3.18 | 4.87 | -15.11 | -60.12 | 7.18 | |||||
Net Income, 3 Yr. CAGR % | -12.37 | 10.79 | -7.13 | -55.52 | 8.22 | |||||
Normalized Net Income, 3 Yr. CAGR % | -1.54 | 1.9 | -11.97 | -2.68 | -4.3 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -6.71 | 18.37 | 2.96 | -49.84 | 11.71 | |||||
Accounts Receivable, 3 Yr. CAGR % | 9.95 | -6.91 | -3.63 | -7.94 | 13.35 | |||||
Inventory, 3 Yr. CAGR % | - | - | - | - | -11.18 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -57.83 | 370.4 | 375.96 | 200.81 | 53.75 | |||||
Total Assets, 3 Yr. CAGR % | 19.11 | 19.33 | 7.55 | 11.99 | 9.91 | |||||
Tangible Book Value, 3 Yr. CAGR % | 39.26 | -3 | -7.54 | 3.87 | 50.36 | |||||
Common Equity, 3 Yr. CAGR % | 39.26 | 21.75 | 7.73 | 18.56 | 27.51 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.63 | -7.81 | -23.34 | -19.66 | -0.8 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | 77.4 | 216.2 | - | 156.52 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 17.22 | -6.06 | -14.87 | -13.13 | -5.23 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 15.78 | -5.07 | -13.09 | -11.28 | -4.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 24.02 | 8.81 | 3.53 | 6.57 | 4.08 | |||||
Gross Profit, 5 Yr. CAGR % | 24.24 | 5.05 | 0 | 4.31 | -1.65 | |||||
EBITDA, 5 Yr. CAGR % | 28.24 | 3.47 | -6.11 | -3.45 | -9.59 | |||||
EBITA, 5 Yr. CAGR % | 28.27 | 3.48 | -7.64 | -3.46 | -9.6 | |||||
EBIT, 5 Yr. CAGR % | 28.27 | 2.95 | -10.25 | -6.01 | -12.18 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 44.02 | 10.41 | -15.05 | -34.29 | -1.59 | |||||
Net Income, 5 Yr. CAGR % | 34.89 | 9.78 | -14.57 | -31.69 | 3.86 | |||||
Normalized Net Income, 5 Yr. CAGR % | 27.47 | 6.03 | -8.05 | -0.49 | -2.66 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 40.18 | 15.22 | -9.02 | -24 | 10.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.77 | -1.9 | 0.19 | 1.69 | -0.13 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -49.57 | 75.05 | 79.95 | 145.9 | 238.72 | |||||
Total Assets, 5 Yr. CAGR % | 19.57 | 27.37 | 17.8 | 12.41 | 10.34 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.28 | 3.34 | 22.68 | 8.2 | 12.5 | |||||
Common Equity, 5 Yr. CAGR % | 3.28 | 18.43 | 34.46 | 17.13 | 16.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 42.93 | 7.31 | -8.8 | -6.03 | -8.86 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 86.4 | 144.29 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 43.36 | 9.26 | -3.12 | -2.26 | -9.38 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 28.07 | 5.71 | -2.57 | -1.23 | -8.43 |
- Stock Market
- Stocks
- INVA Stock
- Financials Innoviva, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















